TABLE 2.
MBIC50 of PN5 and antibiotics against E. coli ATCC 25922, ASEC 2, ASEC 16, and ASEC 18
| Isolate | MBIC50, μM (μg mL−1)a |
|||
|---|---|---|---|---|
| PN5 | Ceftazidime | Cefotaxime | Meropenem | |
| ATCC 25922 | 16 (21.22) | |||
| ASEC 2 | 8 (10.61) | >128 (>69.95) | >128 (>58.3) | 64 (24.54) |
| ASEC 16 | 16 (21.22) | >128 (>69.95) | 128 (58.3) | <2 (<0.77) |
| ASEC 18 | 16 (21.22) | >128 (>69.95) | >128 (>58.3) | <2 (<0.77) |
MBIC50, minimum inhibitory concentration resulting in at least 50% inhibition of biofilm formation.